URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Becker

Concepts (231)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Neoplastic Stem Cells
6
2004
43
2.160
Why?
Leukemia, Myeloid, Acute
5
2006
179
1.780
Why?
Hematopoiesis
3
2002
123
0.740
Why?
Hematopoietic Stem Cells
5
2002
190
0.540
Why?
Cell Transformation, Neoplastic
4
2002
136
0.450
Why?
Muscle, Smooth, Vascular
5
1992
377
0.450
Why?
Stem Cells
1
2006
363
0.430
Why?
Leukemia, Myeloid
3
2006
122
0.380
Why?
Gene Expression Regulation, Neoplastic
4
2002
254
0.370
Why?
Neoplasms
1
2006
723
0.350
Why?
alpha Catenin
2
2006
3
0.340
Why?
Thromboxane A2
3
1993
14
0.300
Why?
Leukemia
2
2006
154
0.300
Why?
Transcription Factors
1
2002
689
0.290
Why?
Tumor Suppressor Protein p53
3
2002
144
0.280
Why?
Apoptosis
1
2002
855
0.280
Why?
Receptors, Prostaglandin
2
1992
7
0.270
Why?
Hematopoietic Stem Cell Transplantation
3
2003
117
0.260
Why?
Cell Differentiation
3
2006
1098
0.260
Why?
Gene Expression Regulation, Leukemic
2
2010
19
0.250
Why?
Animals
13
1992
16270
0.240
Why?
Flow Cytometry
3
2006
597
0.240
Why?
Humans
17
1993
36400
0.230
Why?
Mutation
3
2006
1229
0.220
Why?
Receptors, Thrombopoietin
1
2012
10
0.210
Why?
Hydrazines
1
2012
14
0.210
Why?
Bicyclo Compounds, Heterocyclic
1
1992
14
0.210
Why?
Benzoates
1
2012
16
0.210
Why?
Cell Division
4
1992
766
0.210
Why?
Signal Transduction
3
1993
1626
0.210
Why?
Pyrazoles
1
2012
59
0.210
Why?
Nuclear Proteins
2
2003
330
0.210
Why?
Chemokine CCL3
1
2011
20
0.200
Why?
Growth Substances
1
1992
103
0.200
Why?
Gene Expression Profiling
2
2009
299
0.200
Why?
Genome-Wide Association Study
1
2011
23
0.200
Why?
Antigens, CD34
1
2011
52
0.200
Why?
Thrombocytopenia
1
2012
76
0.200
Why?
Methylprednisolone
1
2011
44
0.200
Why?
Gastrointestinal Tract
1
2011
24
0.200
Why?
Models, Biological
3
2003
1023
0.200
Why?
Translational Medical Research
1
2011
38
0.200
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
132
0.190
Why?
Amifostine
1
2010
28
0.190
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2003
14
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2011
78
0.190
Why?
Down-Regulation
1
1992
244
0.190
Why?
Stem Cell Transplantation
1
2012
113
0.190
Why?
Graft vs Host Disease
1
2011
81
0.190
Why?
Cell Separation
1
2011
227
0.190
Why?
Cytoprotection
1
2010
41
0.190
Why?
Myelopoiesis
1
2010
15
0.190
Why?
Lymphoma, Non-Hodgkin
1
2011
113
0.190
Why?
PTEN Phosphohydrolase
1
2010
16
0.190
Why?
CCAAT-Enhancer-Binding Proteins
1
2010
16
0.180
Why?
Glucocorticoids
1
2011
166
0.180
Why?
Lymphoma
1
2010
163
0.170
Why?
Gene Regulatory Networks
1
2009
6
0.170
Why?
Tumor Markers, Biological
1
2011
228
0.170
Why?
Osteoblasts
1
2011
251
0.170
Why?
Receptors, Thromboxane
3
1992
4
0.170
Why?
Liver
2
2003
876
0.160
Why?
Multipotent Stem Cells
1
2008
11
0.160
Why?
Genes, p16
1
2008
7
0.160
Why?
Osteoclasts
1
2011
336
0.160
Why?
Prognosis
1
2011
1080
0.160
Why?
Genes, p53
1
2008
51
0.160
Why?
DNA Mutational Analysis
1
2008
189
0.150
Why?
Sesquiterpenes
1
2007
25
0.150
Why?
Mice
6
2003
6103
0.150
Why?
Transplantation, Autologous
3
2010
144
0.150
Why?
Myeloid Progenitor Cells
1
2006
4
0.150
Why?
Chromosomes, Human, Pair 5
1
2006
9
0.150
Why?
Disease Models, Animal
1
2011
973
0.150
Why?
Chromosome Deletion
1
2006
62
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
430
0.140
Why?
Neoplasm Transplantation
1
2006
187
0.140
Why?
Repressor Proteins
2
2003
181
0.140
Why?
Multiple Myeloma
1
2006
76
0.140
Why?
Inositol Phosphates
3
1992
36
0.120
Why?
Neoplasm Recurrence, Local
1
2006
286
0.120
Why?
Male
8
1992
19713
0.120
Why?
Cells, Cultured
5
1992
2563
0.120
Why?
Female
7
1999
19826
0.110
Why?
Brain Neoplasms
1
2006
282
0.110
Why?
Leukemia, B-Cell
1
2002
6
0.110
Why?
Oncogene Proteins, Fusion
1
2002
15
0.110
Why?
Zinc Fingers
1
2002
29
0.110
Why?
Thymus Gland
1
2002
143
0.100
Why?
Proto-Oncogene Proteins
1
2003
297
0.090
Why?
Prostatic Neoplasms
1
2006
556
0.090
Why?
Arthroplasty, Replacement, Knee
1
1999
21
0.090
Why?
Breast Neoplasms
1
2006
675
0.090
Why?
Patients
1
1999
47
0.090
Why?
Arthroplasty, Replacement, Hip
1
1999
46
0.090
Why?
Attitude
1
1999
64
0.090
Why?
Middle Aged
5
1999
9877
0.080
Why?
HL-60 Cells
2
2006
52
0.080
Why?
Adult
5
1999
11345
0.080
Why?
DNA-Binding Proteins
1
2002
687
0.070
Why?
Blotting, Western
2
2006
668
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
543
0.070
Why?
Prostaglandin Endoperoxides, Synthetic
2
1992
5
0.070
Why?
Acute Disease
2
2006
580
0.070
Why?
Fibroblast Growth Factors
1
1994
44
0.060
Why?
Mice, Inbred C57BL
2
2008
1683
0.060
Why?
Treatment Outcome
2
2011
2623
0.060
Why?
Myosin-Light-Chain Kinase
1
1993
13
0.060
Why?
Rats
4
1992
4386
0.060
Why?
Phosphorylation
2
1993
833
0.060
Why?
Fibroblast Growth Factor 2
1
1993
84
0.060
Why?
DNA
3
1992
856
0.060
Why?
Vasoconstrictor Agents
1
1992
31
0.060
Why?
Rats, Sprague-Dawley
2
1992
1028
0.050
Why?
Isometric Contraction
1
1992
47
0.050
Why?
Bicyclo Compounds
1
1992
1
0.050
Why?
Thromboxanes
1
1992
7
0.050
Why?
Platelet Count
1
2012
49
0.050
Why?
Prostaglandins
1
1992
67
0.050
Why?
Protein Kinase C
1
1994
256
0.050
Why?
Fatal Outcome
1
2012
109
0.050
Why?
Blood
1
1992
95
0.050
Why?
Fatty Acids, Unsaturated
1
1992
32
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2011
26
0.050
Why?
Immunocompetence
1
2011
30
0.050
Why?
Aged
3
1999
7272
0.050
Why?
Muscle Contraction
1
1993
177
0.050
Why?
Injections, Intra-Arterial
1
2011
31
0.050
Why?
Aorta
1
1992
194
0.050
Why?
Hydrogen-Ion Concentration
1
1993
571
0.050
Why?
Transplantation, Homologous
1
2012
260
0.050
Why?
Diphosphonates
1
2011
43
0.050
Why?
Imidazoles
1
2011
69
0.050
Why?
Remission Induction
1
2011
163
0.050
Why?
Pancytopenia
1
2010
14
0.050
Why?
Maximum Tolerated Dose
1
2010
18
0.050
Why?
Melphalan
1
2010
27
0.050
Why?
Immunoenzyme Techniques
1
2011
220
0.050
Why?
Mucositis
1
2010
14
0.050
Why?
Bone Density Conservation Agents
1
2011
51
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
21
0.050
Why?
Transplantation Conditioning
1
2010
31
0.050
Why?
Carmustine
1
2010
37
0.050
Why?
Medical Records
1
2011
125
0.050
Why?
Drug Resistance
1
2011
101
0.050
Why?
Cytarabine
1
2010
91
0.050
Why?
Etoposide
1
2010
83
0.050
Why?
RNA, Messenger
2
2003
1857
0.050
Why?
Polymerase Chain Reaction
2
1994
594
0.050
Why?
Frameshift Mutation
1
2010
23
0.050
Why?
Zebrafish
1
2010
28
0.050
Why?
Spleen
1
2011
339
0.050
Why?
Bone Marrow
1
2011
290
0.050
Why?
Transcription, Genetic
2
1994
815
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
466
0.040
Why?
Protein Isoforms
1
2010
115
0.040
Why?
Survival Rate
1
2011
619
0.040
Why?
Bone Resorption
1
2011
243
0.040
Why?
Survival Analysis
1
2011
598
0.040
Why?
Atrial Fibrillation
1
2010
115
0.040
Why?
Databases, Nucleic Acid
1
2009
4
0.040
Why?
Combined Modality Therapy
1
2010
486
0.040
Why?
Protein Processing, Post-Translational
1
2010
145
0.040
Why?
Biological Availability
1
2007
40
0.040
Why?
Exons
1
2008
163
0.040
Why?
Cell Proliferation
1
2011
521
0.040
Why?
Drug Design
1
2007
45
0.040
Why?
Cell Count
1
2008
286
0.040
Why?
Dose-Response Relationship, Drug
1
2010
1138
0.040
Why?
U937 Cells
1
2006
18
0.040
Why?
K562 Cells
1
2006
22
0.040
Why?
Hydroxamic Acids
1
2006
21
0.040
Why?
Severity of Illness Index
1
2011
919
0.040
Why?
Dogs
1
2007
488
0.040
Why?
Promoter Regions, Genetic
1
2010
552
0.040
Why?
DNA Methylation
1
2006
34
0.040
Why?
Structure-Activity Relationship
1
2007
318
0.040
Why?
In Situ Hybridization, Fluorescence
1
2006
111
0.040
Why?
Mice, Knockout
1
2010
918
0.040
Why?
Antineoplastic Agents
1
2011
625
0.030
Why?
Postoperative Complications
1
2010
743
0.030
Why?
Young Adult
1
2010
1074
0.030
Why?
Green Fluorescent Proteins
1
2006
218
0.030
Why?
Infant
1
2011
2249
0.030
Why?
Myelodysplastic Syndromes
1
2006
133
0.030
Why?
Tumor Cells, Cultured
1
2007
863
0.030
Why?
Sensitivity and Specificity
1
2008
905
0.030
Why?
Reproducibility of Results
1
2008
884
0.030
Why?
Retrospective Studies
1
2011
2260
0.030
Why?
Cell Line, Tumor
1
2006
576
0.030
Why?
Oxidative Stress
1
2007
352
0.030
Why?
Gene Expression Regulation
2
1994
875
0.030
Why?
Tumor Suppressor Protein p14ARF
1
2003
6
0.030
Why?
Hypertrophy
2
1992
71
0.030
Why?
NF-kappa B
1
2007
443
0.030
Why?
Transfection
1
2006
876
0.030
Why?
Child
1
2011
4086
0.030
Why?
Gene Deletion
1
2003
205
0.030
Why?
Bone Marrow Transplantation
1
2003
186
0.030
Why?
Cell Line
1
2006
1594
0.030
Why?
Bone Marrow Cells
1
2003
223
0.030
Why?
Group Practice
1
1999
13
0.020
Why?
Hospitals, General
1
1999
17
0.020
Why?
Orthopedics
1
1999
39
0.020
Why?
Sex Factors
1
1999
584
0.020
Why?
Age Factors
1
1999
1121
0.020
Why?
Phorbol Esters
1
1994
18
0.020
Why?
Prospective Studies
1
1999
1677
0.020
Why?
Questionnaires
1
1999
998
0.020
Why?
Immunoblotting
1
1994
222
0.010
Why?
Quinones
1
1993
13
0.010
Why?
Lactams, Macrocyclic
1
1993
16
0.010
Why?
Benzoquinones
1
1993
18
0.010
Why?
Angiotensin II
1
1994
138
0.010
Why?
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
1
1992
6
0.010
Why?
Dinoprost
1
1992
28
0.010
Why?
Thymidine
1
1992
86
0.010
Why?
Leucine
1
1992
109
0.010
Why?
Tyrosine
1
1993
145
0.010
Why?
Protein Kinase Inhibitors
1
1993
94
0.010
Why?
Binding, Competitive
1
1992
209
0.010
Why?
Aged, 80 and over
1
1999
2513
0.010
Why?
Cytosol
1
1992
194
0.010
Why?
United States
1
1999
2630
0.010
Why?
Up-Regulation
1
1993
372
0.010
Why?
Dinoprostone
1
1992
207
0.010
Why?
Protein Biosynthesis
1
1992
265
0.010
Why?
Kinetics
1
1992
1464
0.010
Why?
Base Sequence
1
1993
1704
0.010
Why?
Molecular Sequence Data
1
1993
2028
0.010
Why?
Calcium
1
1992
1127
0.010
Why?

Visualizations


Becker's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department